Since researchers discovered that ketamine was able to produce rapid and highly effective symptom relief for treatment-resistant depression and other hard to treat mental health disorders, many more efforts have been invested in the research and development of depression treatments. Researchers have a new understanding of how depression affects brain function, and the areas of the brain that need to be manipulated in order to alleviate depressive and psychotic symptoms.

But while researchers are seeing the brain in a who new light, research goals need to be better aligned with what patients want to achieve through depression treatment. Scientists are thrilled by answering questions about how the brain functions, and how patients respond to chemical interactions on a cellular level, but the individual who is suffering cares more about how they feel after receiving treatment, and how long it takes them to experience relief. In response to this sentiment, the Milken Institute and the Depression and Bipolar Support Alliance has been collecting the perspectives of patients with depression or bipolar disorder.

A first-of-its-kind survey was released, asking patients how they would prioritize depression research, and what their definition of wellness was. The results have confirmed that a patient’s primary concern is finding good treatment options quickly—for example, being prescribed a medication that is more likely to work for their unique symptoms the first time around, eliminating the need to try several medications before finding the one that works for them. However, one surprising finding was that many patients were also curious about the cause of their mental health disorder.

Listening to what depressed patients want and need is a step that will help scientists define specific goals and keep their research focused on improving the lives of millions, without getting distracted by the unlimited number of questions surrounding mental health and brain functionality. Unless a person is depressed or suffering from anxiety, PTSD or any other psychiatric disorder, it’s impossible to understand what it feels like to suffer from this affliction. Many individuals who suffer cannot even fully describe how it feels, making it difficult to help researchers understand their symptoms and needs. By giving the patients a bigger voice, we will light the path for properly intentioned research and development efforts.

Contact Interpersonal Advanced Treatment

If you or a loved one is suffering from depression or another psychiatric disorder, please contact our caring, professional staff for a free consultation. Ketamine infusions are proven to alleviate symptoms in 70% of depressed patients, often times working after only one or two infusions. If you are frustrated that first-line depression treatments aren’t helping, ketamine may be the solution you’ve been looking for. Contact us today to learn more.